Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pemirolast potassium
Cat. No.:
OB0225LY-0120
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Pemirolast potassium is an anti-allergic drug that acts primarily on mast cells to inhibit histamine release.
Synonym:
100299-08-9; 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one, potassium salt; 4H-Pyrido(1,2-a)pyrimidin-4-one, 9-methyl-3-(1H-tetrazol-5-yl)-, potassium salt
CAS No.:
100299-08-9
Compound CID:
443866
Formula:
C10H7KN6O
Formula Weight:
266.31
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pemirolast potassium can be used to study allergic conjunctivitis and other allergic reactions.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
GPCR/G protein; Neuronal signaling; Immunology/Inflammation
Plate Number:
AOCL-2
Plate Location:
e3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM Water
Water Max Solubility:
10 mM
Solubility:
Insoluble in DSMO.
